Skip to main content
IART logo

IART · Integra Lifesciences Holdings Corp · Analyst Estimates

Track IART — free
$16.28 -0.36 (-2.16%) At close · Sep 30
Market Cap
$1.25B
Shares
77.77M
Volume · Sep 30 768.92K Avg daily vol (3M) 851.61K

Analyst Estimates

Compare analyst forecasts for Integra Lifesciences Holdings Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 19:43 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.40699
2.45695
2.5
—
2.45695
2.44978
2.45695
2.44862
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
0
0
5
5
Revenue
USD
Publication date not stated
1666980760
1674473970
1685500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.5
2.60846
2.73
—
2.60512
2.61783
2.60846
2.61062
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
5
0
4
1
Revenue
USD
Publication date not stated
1704903780
1727595570
1752500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.53387
0.56337
0.59
—
0.56337
0.55941
0.56337
0.56045
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
5
5
3
4
Revenue
USD
Publication date not stated
410753510
416301460
422100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.74292
0.80314
0.89
—
0.80314
0.86777
0.80314
0.86641
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
8
9
0
0
Revenue
USD
Publication date not stated
441890650
447367320
453900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 917520 CUSIP 457985208 13F (30d) 6 filings 6 filers Visit website Investor relations